Considerations for defining medication exposure when analyzing real-world data.

Pharmacoepidemiol Drug Saf

Resesarch, The Reagan-Udall Foundation for the FDA, Washington, District of Columbia, USA.

Published: August 2023

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.5613DOI Listing

Publication Analysis

Top Keywords

considerations defining
4
defining medication
4
medication exposure
4
exposure analyzing
4
analyzing real-world
4
real-world data
4
considerations
1
medication
1
exposure
1
analyzing
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!